Clinical Trial Update: A Study of BL-B01D1, SI-B003 and BL-B01D1+SI-B003 in Patients With Extensive Stage Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating BL-B01D1, SI-B003, and their combination in extensive-stage small cell lung cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• BL-B01D1
• BL-B01D1 + SI-B003
• SI-B003

Snippet

Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. | Conditions: Small Cell Lung Cancer | Phase 2 | Status: RECRUITING